SCHEMBL6788959

SCHEMBL6788959

Cc1ccc(-c2nnn[nH]2)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
APOBEC3G Q9HC16 1/20 0.45
CYP3A4 P08684 1/20 0.37
KMO O15229 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KDM4E B2RXH2 3/20 0.36
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 1/20 0.35
IKBKB O14920 2/20 0.34
PTGS2 P35354 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
CHEK2 O96017 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20339943 0.86 NPBWR1 (0.40) ALDH1A1APOBEC3GPOLBIKBKBPTGS2
SCHEMBL703287 0.84 AHR (0.48) ALDH1A1KMONPC1RAB9AKDM4E
SCHEMBL5822962 0.84 NOTUM (0.41) ALDH1A1NPC1RAB9AMAPTMEN1
SCHEMBL13239549 0.80 IKBKB (0.33) IKBKB
SCHEMBL25065199 0.79 PIK3CD (0.40) ALDH1A1CYP3A4KDM4ENPSR1MAPT
SCHEMBL22878421 0.79 NISCH (0.44) KMOPTGS2MAPT
SCHEMBL23291740 0.79 KDM4E (0.33) KDM4EMAPT
SCHEMBL4399156 0.79 ALDH1A1 (0.52) ALDH1A1CYP3A4NPC1RAB9AKDM4E
SCHEMBL8217792 0.79 ESR2 (0.46) PTGS2TSHRHSD17B10
SCHEMBL6621917 0.79 NPC1 (0.35) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6787556-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) AGONISTS; type 2 gamma receptors; INSULIN RESISTANCE; carboxybenzyl group on a phenyl-substituted tetrazole, pyrazole, or imidazole ring ASTRAZENECA AB (SE) 2004-09-07 US disclosed
EP-1210339-A1 BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS AstraZeneca AB (SE) 2002-06-05 EP disclosed
EP-1150972-A1 TRIAZOLE AND TETRAZOLE DERIVATIVES, AND THEIR THERAPEUTIC USE SANOFI-SYNTHELABO (FR) 2001-11-07 EP disclosed
WO-2001012612-A1 BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS ASTRAZENECA AB (SE) 2001-02-22 WO disclosed
WO-2000046220-A1 TRIAZOLE AND TETRAZOLE DERIVATIVES, AND THEIR THERAPEUTIC USE SANOFI-SYNTHELABO (FR) 2000-08-10 WO disclosed